The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Losing weight is a common New Year’s resolution, and many people are now turning to advanced weight-loss medications like ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

GLP-1 medications like Ozempic have shown promise as treatment for symptoms caused by Polycystic Ovary Syndrome (PCOS). I ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

GLP-1 medications like Wegovy and Ozempic have become popular options for managing conditions like diabetes and obesity, but hair loss is a lesser-known side effect.